ImmuCell Corp. (ICCC)
9.84
-0.06
(-0.61%)
USD |
NASDAQ |
Sep 08, 16:00
9.97
+0.13
(+1.32%)
After-Hours: 20:00
ImmuCell Debt to Equity Ratio : 0.3967 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3967 |
| March 31, 2026 | 0.4386 |
| December 31, 2025 | 0.4877 |
| September 30, 2025 | 0.4566 |
| June 30, 2025 | 0.4776 |
| March 31, 2025 | 0.5056 |
| December 31, 2024 | 0.5487 |
| September 30, 2024 | 0.5881 |
| June 30, 2024 | 0.6752 |
| March 31, 2024 | 0.6605 |
| December 31, 2023 | 0.6678 |
| September 30, 2023 | 0.6413 |
| June 30, 2023 | 0.5622 |
| March 31, 2023 | 0.4695 |
| December 31, 2022 | 0.4108 |
| September 30, 2022 | 0.3979 |
| June 30, 2022 | 0.3619 |
| March 31, 2022 | 0.3606 |
| December 31, 2021 | 0.3154 |
| September 30, 2021 | 0.3232 |
| June 30, 2021 | 0.3194 |
| March 31, 2021 | 0.3775 |
| December 31, 2020 | 0.3797 |
| September 30, 2020 | 0.3916 |
| June 30, 2020 | 0.394 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3404 |
| December 31, 2019 | 0.2905 |
| September 30, 2019 | 0.2958 |
| June 30, 2019 | 0.2984 |
| March 31, 2019 | 0.2994 |
| December 31, 2018 | 0.4491 |
| September 30, 2018 | 0.418 |
| June 30, 2018 | 0.3997 |
| March 31, 2018 | 0.391 |
| December 31, 2017 | 0.3796 |
| September 30, 2017 | 0.2802 |
| June 30, 2017 | 0.2091 |
| March 31, 2017 | 0.1603 |
| December 31, 2016 | 0.1527 |
| September 30, 2016 | 0.1856 |
| June 30, 2016 | 0.1886 |
| March 31, 2016 | 0.1909 |
| December 31, 2015 | 0.304 |
| September 30, 2015 | 0.3166 |
| June 30, 2015 | 0.0806 |
| March 31, 2015 | 0.087 |
| December 31, 2014 | 0.0968 |
| September 30, 2014 | 0.1036 |
| June 30, 2014 | 0.109 |
| March 31, 2014 | 0.1107 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 46.63M |
| Total Liabilities (Quarterly) | 15.26M |
| Shareholders Equity (Quarterly) | 31.37M |
| Current Ratio | 4.752 |
| Net Debt Paydown Yield | 0.48% |